PSI CRO Holding AG is a contract research organization (CRO) that plans and conducts Phase 2 and Phase 3 clinical trials, providing study design, patient enrollment and study management services. The company works across therapeutic areas including oncology, gastroenterology, hematology, cell and gene therapy, neurology, infectious diseases and radiopharmaceuticals, and offers digital platforms for feasibility analysis and site intelligence.
AI-generated
Offering
Products & services
Industry:Holding Companies
✓ Offered
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Full-service Contract Research Organization for clinical studies, focused on timely execution, budget adherence, project management and sponsor support.
Conducting Phase 2 and Phase 3 studies
On-time enrollment in pivotal Phase 2 & 3 clinical trials, with support in start-up, recruitment, trial execution and close-out of complex studies.
Therapeutic specialization for clinical studies
Clinical studies in oncology, haematology, gastroenterology, cell and gene therapy, neurology, infectious diseases, radiopharmaceuticals, respiratory diseases and other indications.
Support for complex clinical projects
Support for demanding clinical projects, including platform and umbrella designs, targeted immunotherapy, radiopharmaceuticals as well as cell and gene therapies.
Knowledge
No knowledge articles yet
Once PSI CRO Holding AG has claimed this profile, we'll publish editorial articles and case studies here together.